Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Systematic review and meta-analysis of 4630 myeloma pts finds CN palsies most frequent (32.3%; 43 events) non-ICANS neuro tox post-BCMA CAR T, then movement and neurocognitive TEAEs (12%; 16 events), peripheral neuropathies.”
Title: Non-ICANS Neurologic Toxicity after BCMA CAR T: A systematic review and meta-analysis of 4630 multiple myeloma patients
Authors: Herman J. van Besien, Gwynne Ozkan, Neela Easton, Tobias Tix, Mohammad Alhomoud, Roni Shouval, Kai Rejeski, Samuel Yamshon
You can read the Full Article in Blood Advances.
You can find other articles featuring Robert Orlowski on OncoDaily.
